Close Menu

Somalogic

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference kicked off here Monday with several life science tools and diagnostic firms making presentations to investors and other attendees.

SomaLogic has named Byron Hewett as CEO. Hewett takes replaces Larry Gold, who will continue serving the Boulder, Colo.-based company as chairman of the board. Gold will also work as a full-time adviser, SomaLogic said.

Somalogic this week named Byron Hewett CEO, replacing Larry Gold who will continue as chairman of the board and as a full-time employee at the company.

SomaLogic Raises $10M

NEW YORK (GenomeWeb News) – SomaLogic has raised $10 million in equity financing, the company said in a document filed with the US Securities and Exchange Commission on Tuesday.

Agilent and SomaLogic said this week that they have entered an agreement to expand access to SomaLogic's SOMAscan protein biomarker discovery platform by placing it in select academic and contract research centers.

NEW YORK (GenomeWeb News) – Agilent and SomaLogic said today that they have entered an agreement to expand access to Somalogic's SOMAscan protein biomarker discovery platform by placing it in select academic and contract research centers.

On a conference call last month following the release of its Q1 earnings, Vermillion CEO Thomas McLain announced that the company would be taking over from Quest Diagnostics as leader of commercialization efforts for its OVA1 ovarian cancer diagnostic (

Researchers led by the Harvard Stem Cell Institute and Brigham and Women's Hospital have identified a protein — GDF11 — using Somalogic's Somascan technology, that they showed can reverse features of age-related heart disease in mice.

British diagnostic tools provider Avacta plans to introduce a new high-density protein microarray platform for use in drug and biomarker discovery by the end of next year, CEO Alastair Smith told BioArray News this week.

Under its new Parkinson's Disease Biomarker Program, the National Institute of Neurological Disorders and Stroke has funded nine research teams, most of which involve proteomic approaches, to attempt to identify biomarkers that could be used as either predictive or prognostic too

Pages

The Associated Press reports that a state board in Texas has asked ANDE, a maker of rapid DNA machines, to halt its work there.

James Wyngaarden, the former director of the US National Institutes of Health, has died at 94, according to Duke University School of Medicine.

Researchers find that a 30-year-old skull comes from a narwhal-beluga hybrid, according to Science News.

In Nature this week: study of value diversity in GWAS, Epstein-Barr virus subtypes linked to nasopharyngeal carcinoma risk, and more.